You are here: Home » Companies » News
Business Standard

Israel's Super-Pharm in talks to buy Teva plant

Super-Pharm, which already operates laboratories providing custom-made treatments, did not confirm the talks but said it would be interested in a deal

Reuters  |  Tel Aviv 

Israel’s largest pharmacy chain Super-Pharm (Israel) is in talks to acquire Teva Pharmaceutical Industries’ plant in the coastal city of Ashdod, a source familiar with the matter said on Sunday, confirming media reports. Super-Pharm would pay 60-80 million shekels ($17-23 million) and is prepared to commit to continue employing the factory’s 70 workers, said the source, who asked not to be named. Super-Pharm is interested in the pharmaceutical preparation activities that have an estimated 100 million shekels in annual sales, the Globes financial news site ...

This article is no longer available in our repository.

There could be multiple reasons for this.

First Published: Mon, December 25 2017. 01:42 IST